Loading clinical trials...
Loading clinical trials...
A Prospective, Randomized, Open-labelled, Controlled Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With Diagnosis of COVID-19.
Conditions
Interventions
Standard COVID-19 care
Quercetin Phytosome
Locations
1
Pakistan
Liaquat University Hospital
Jāmshoro, Sindh, Pakistan
Start Date
September 29, 2020
Primary Completion Date
March 28, 2021
Completion Date
April 15, 2021
Last Updated
April 22, 2021
NCT06082518
NCT07221162
NCT06631287
NCT06679140
NCT06417762
NCT03830320
Lead Sponsor
Liaquat University of Medical & Health Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions